Biomerica rises after securing first major European order for stomach infection test

Biomerica

18/03/2026 12:29

** Shares of diagnostics maker Biomerica BMRA.O rise 8.2% to $2.25 premarket

** Co says it secured its first commercial European order for its Hp Detect stool test from one of Europe’s largest lab chains

** Test detects H. pylori, a common stomach bacteria that can cause ulcers and stomach cancer and is hard to treat due to antibiotic resistance - BMRA

** Order is for the UK market and follows approval from the UK medicines regulator in February, co says

** Adds the lab chain’s wide reach could help expand sales across Europe and lead to repeat orders as testing becomes routine

** Says H. pylori affects about 45% of people in Europe’s five biggest countries

** BMRA rose ~5% in 2025

(Reporting by Sahil Pandey in Bengaluru)

((Sahil.Pandey@thomsonreuters.com))